Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2858 (LINC02858)

Target
LINC02858
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

Long intergenic non-protein coding RNA 2858 (LINC02858) is a human long non-coding RNA (lncRNA), transcribed from a genomic region that does not overlap with protein-coding genes[1][3][7]. It is classified as an lncRNA based on its structure and lack of protein-coding potential[3]. As with many lncRNAs, its specific biological function is uncharacterized; current databases such as BioGPS and GeneCards do not list experimentally defined roles, tissue specificity, or direct disease associations for LINC02858[1][3]. Genome-wide association catalogs note its presence at the transcript level but do not report specific phenotypic or drug-interaction data[5]. It is not considered a classical pharmacological or therapeutic target (such as a receptor, enzyme, or transporter). No aliases beyond "LINC02858" and its full name are documented in gene nomenclature consortia[1][7]. There is no evidence of transcription factor activity, receptor function, enzymatic activity, or transporter capacity. Additionally, there is no data supporting its direct use as a biomarker, nor are any drugs known to target this transcript.

Other names
LINC02858
02

Biological functions

Other (no experimentally confirmed biological functions found; lncRNAs are often involved in transcriptional regulation, chromatin remodeling, and gene expression modulation in general)
03

Disease associations

Other (no definitive association with a specific disease, but lncRNAs can be implicated in various conditions, especially cancers)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2858 (LINC02858).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2858 (LINC02858).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call